Home » Topics » BioWorld Science, Hematologic

BioWorld Science, Hematologic
RSS

China's NMPA approves roxadustat for anemia in patients with CKD not receiving dialysis

Aug. 22, 2019

Results presented from phase III HOPE study of voxelotor in sickle cell disease

Aug. 22, 2019

Targeting NuRD for derepression of fetal hemoglobin in hemoglobinopathies

Aug. 22, 2019

Pharmadiall presents new coagulation factor Xa inhibitors

Aug. 14, 2019

Mitsubishi Tanabe Pharma announces initiation of development of gene therapy for hemophilia B

Aug. 6, 2019

Pivotal phase III RESET study of rivipansel does not meet primary nor key secondary endpoints

Aug. 5, 2019

Momenta Pharmaceuticals launches phase II/III study of nipocalimab in wAIHA

Aug. 2, 2019

FDA approves Accrufer for iron deficiency in adults

July 29, 2019

First-generation PI3KC2alpha inhibitors as promising antithrombotic agents

July 23, 2019

Discovery and preclinical identification of novel NOX1-selective inhibitor, 2APT-PD06

July 23, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
Capital remains selective in ‘barbell’ biotech market
BioWorld
Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...
PSB-229 reduces plaque burden in Alzheimer’s models
BioWorld Science
Pyroglutamate-modified amyloid-β (pE3-Aβ) is a highly pathogenic Aβ species that accumulates within amyloid plaques and contributes to aggregation,...